Protective effect of Emilia sonchifolia on azaserine-induced pancreatic dysplasia  by Sophia, Dominic et al.
Available online at www.sciencedirect.comScienceDirect
Journal of Acute Medicine 4 (2014) 68e74
www.e-jacme.comOriginal Research
Protective effect of Emilia sonchifolia on azaserine-induced pancreatic
dysplasia
Dominic Sophia, Paramasivam Ragavendran, Chinthamony Arul Raj,
Velliyur Kanniappan Gopalakrishnan*
Department of Biochemistry, Karpagam University, Coimbatore 641 021, Tamil Nadu, India
Received 4 July 2013; accepted 11 February 2014
Available online 26 April 2014AbstractAim: The present study was undertaken to investigate the effect of Emilia sonchifolia on azaserine (O-diazoacetyl-L-serine)-induced pancreatic
dysplasia in Wistar albino rats.
Methods: Administration of azaserine [30 mg/kg body weight intraperitoneal (i.p.) weekly for 1 month] to male Wistar albino rats resulted in
pancreatic dysplasia, which was evident from the histopathological studies.
Results: A significant decrease of pancreatic and hepatic enzymatic antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GPx), glutathione-S-transferase (GST), and non-enzymatic antioxidants like vitamin C, glutathione (GSH) content, and a significant
increase in pancreatic serum amylase and lipase, and hepatic marker enzymes aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and alkaline phosphatase (ALP) were found. Treatment of rats with the n-hexane extract of Emilia sonchifolia for 16 weeks resulted in a
concomitant reduction in pancreatic and hepatic damage.
Conclusion: The results suggest that Emilia sonchifolia can be used as a therapeutic agent against precancerous lesions which could prevent
pancreatic dysplasia.
Copyright  2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Pancreatic cancer is one of the most lethal cancers, with
most patients dying of their disease within 1 year; it is the
fourth leading cause of cancer deaths in the United States.
Pancreatic cancer accounts for about 220,000 deaths each
year. Smoking, obesity, and diabetes are important and are
potentially modifiable risk factors for pancreatic cancer in
populations of the Asia-Pacific region. Activities to prevent
them can be expected to lead to a major reduction in the* Corresponding author. Department of Biochemistry, Karpagam University,
Coimbatore 641 021, Tamil Nadu, India.
E-mail address: vkgopalakrishnan@gmail.com (V.K. Gopalakrishnan).
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2211-5587/Copyright  2014, Taiwan Society of Emergency Medicine. Publishednumber of deaths from this cancer, particularly in Asia with its
enormous population.1
The only US Food and Drug administration approved
therapies for pancreatic cancer, gemcitabine and erlotinib,
produce objective responses in <10% of patients. The
increased oxidative stress is also highly associated with the
induction of pancreatic cancer. Reactive oxygen species (ROS)
and other free radicals may contribute to cancer initiation
through oxidative damage and nitration of DNA, thus inducing
mutations.2 The enforced expression of antioxidant enzymes
has profound effects in altering the malignant phenotype of
pancreatic cancer both in vitro and in vivo.3
Azaserine (O-diazoacetyl-L-serine) is a direct-acting bac-
terial mutagen and a pancreatic carcinogen in Wistar rats.
Previous studies have demonstrated that azaserine isby Elsevier Taiwan LLC. All rights reserved.
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major abnormalities of growth and differentiation of the
exocrine pancreas, including adenocarcinoma in some rats.4
Lifestyle and/or environmental factors, especially dietary
factors, play an important role in influencing cancer risk. A
large number of medicinal plants and their active constituents
have shown beneficial therapeutic potential against the risk of
cancer. For centuries, people have been using herbs for me-
dicinal purposes. In fact, the use of herbal medicine can be
traced back at least 5000 years.
Recently, a greater emphasis has been given towards research
on complementary and alternative medicine that deals with
cancer management. Plants have a long history of use in the
treatment of cancer and have been traditionally used as medi-
cines in many countries. Even in the USA, the use of plants and
phytomedicine has increased dramatically in the past 2 de-
cades.5 Medicinal plants are promising sources of potential
antioxidants.6 There is a well-documented association between
increased consumption of antioxidants and decreased incidence
of cancer.7 Antioxidants have received increased attention by
nutritionists andmedical researchers for their potential effects in
the prevention of cancer. Therefore, there is an ongoing search
for better controlling and preventive methods in order to reduce
cancer mortality and related side effects.8
Emilia sonchifolia (Asteraceae) is a well-known annual
weed seen in most tropical and subtropical regions worldwide.
It is an edible plant used in the Ayurvedic system of medicine
for the treatment of tumors, inflammation, cough, rheumatism,
and wounds.9 Fresh juice and the methanolic extract of E.
sonchifolia leaves were found to be potent inhibitors of hy-
droxyl radical formation and superoxide radical generation
in vitro.10 The aqueous and methanol extracts of E. sonchifolia
leaves progressively reduced rat paw edema.11 The n-hexane
extract of E. sonchifolia possesses a good antioxidant activity
and the high performance thin layer chromatography deter-
mination showed the presence of terpenoids.12 The present
study was undertaken to evaluate the protective effect of E.
sonchifolia on azaserine-induced pancreatic dysplasia.
2. Methods2.1. Collection of plant materialE. sonchifolia was collected in September 2009 from
Thrissur, Kerala, India. The plant was authenticated by Dr.
G.V.S Moorthy, Botanical Survey of India, Tamil Nadu
Agricultural University (TNAU) campus Coimbatore, with the
voucher number BSI/SRC/5/23/09-10/Tech/782. The whole
plant material was washed under running tap water, air dried,
finely powdered, and stored in airtight bottles.2.2. Extraction of plant materialPlant powder (500 g) was soaked in n-hexane solvent and
kept in the shaker for 48 hours at room temperature. The extract
was collected and concentrated at 40C under reduced pressure
using a rotary evaporator. The dried extract was stored at 4Cuntil further use. The remaining residue was extracted again
with the fresh solvent to ensure complete extraction.2.3. AnimalsThe male Wistar rats (2e3 weeks old) were procured from
the animal house of Karpagam University, Coimbatore. The
animals were caged in well ventilated hygienic conditions and
were given food and water ad libitum during the course of the
experiment. The study was approved by the Institutional An-
imal Ethical Committee (IAEC) constituted for the purpose of
Committee for the Purpose of Control and Supervision of
Experiments on Animals (CPCSEA), Government of India.2.4. Experimental designThe animals were divided into four groups of six rats each:
Group I e control, Group II e animals administered with intra-
peritoneal (i.p.) injection azaserine at a dose of 30 mg/kg body
weight, Group III e azaserine þ treatment with the n-hexane
extract ofE. sonchifolia (250mg/kg bodyweight) continued for a
period of 16 weeks, Group IVe the n-hexane extract of E. son-
chifolia alone (250 mg/kg body weight) for 16 weeks.2.5. Induction of carcinogenesis in ratsAzaserine (Sigma Chemical Co., St. Louis, MO, USA)
dissolved in 0.9% NaCl solution was injected i.p. at a dose of
30 mg/kg body weight once weekly for 4 successive weeks
and sacrificed after 16 weeks.2.6. Determination of serum biochemical parametersAfter the experimental period of 16 weeks, the animals
were sacrificed under light chloroform anesthesia. Blood was
drawn from the paraorbital venous complexes and serum
separation tubes, allowed to clot for 30 minutes at room
temperature, and then centrifuged at 1000g for 10 minutes and
stored at 4C. Biochemical parameters such as aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
alkaline phosphatase (ALP), amylase, and lipase were esti-
mated within 6 hours of animal sacrifice. The liver and
pancreas were excised immediately, cleaned free of extraneous
material and perfused with ice cold saline (0.9%) and stored in
10% formalin, which are used for the antioxidant and histo-
pathological studies, respectively.2.7. Estimation of tissue lipid peroxidationLipid peroxidation (LPO)13 was calculated on the basis of
the molar extinction coefficient of malondialdehyde (MDA)
and expressed in terms of nanomoles of MDA/mg protein.2.8. Estimation of antioxidant assaysThe enzymatic antioxidants such as superoxide dismutase
(SOD),14 catalase (CAT),15 glutathione peroxidase (GPx),16
Table 2
Effects of the n-hexane extract of Emilia sonchifolia on the activities of serum
amylase and lipase.
Groups Amylase (U/L)d Lipase (U/L)d
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antioxidants such as reduced glutathione (GSH)18 and
vitamin C were evaluated in the tissue homogenates of the
liver and pancreas.Normal control 157.88  0.32a 11.35  0.20a
Azaserine control 366.24  0.98b 45.39  0.45b
c c
2.9. Statistical analysisAzaserine þ plant extract
(250 mg/kg)
178.27  0.71 20.70  0.50
Plant extract alone
(250 mg/kg)
157.69  0.42a 11.29  0.32a
Values are expressed as mean  standard deviation for six animals.
Units: amylase ¼ amount of starch in mg hydrolyzed in 20 minutes;
lipase ¼ the acid released to neutralize 1 mL of N/10 NaOH.
a Groups I and IV sharing common superscript “a” do not differ significantlyThe results obtained were expressed as mean  standard
deviation (SD). The statistical comparisons among the groups
were performed using one-way analysis [ANOVA; SPSS
version 10.0 (SPSS Inc., Chicago, IL, USA)] at p < 0.05 level.
3. Results
at p < 0.05 (Duncan Multiple Range Test).
b,c Groups II and III with the superscripts “b” and “c”, respectively, differ
significantly at p < 0.05 (Duncan Multiple Range Test).
d Values not sharing common superscript letters differ significantly at
p < 0.05 (Duncan Multiple Range Test).3.1. Effects of the n-hexane extract of E. sonchifolia on
the serum biochemical parameters of azaserine- induced
experimental animalsThe effects of the n-hexane extract of E. sonchifolia on
serum of control and experimental animals are shown in
Tables 1 and 2. The serum liver maker enzymes AST, ALT,
ALP, and pancreatic enzymes amylase and lipase were found
to be significantly (p < 0.05) increased in Group II azaserine-
induced animals when compared with Group I control ani-
mals. Treatment with the n-hexane extract of E. sonchifolia
(Group III) showed a significant (p < 0.05) decrease in serum
AST, ALT, ALP, amylase, and lipase levels. There was no
significant change between the control Group I and the n-
hexane extract of E. sonchifolia alone treated Group IV
animals.3.2. Effects of the n-hexane extract of E. sonchifolia in
the liver of control and pancreatic cancer induced
experimental animalsPancreatic cancer induction in rats caused a significant
(p < 0.05) increase in hepatic LPO level and decreased the
activities of SOD, CAT, GPx, GST, GSH, and vitamin CTable 1
Effects of the n-hexane extract of Emilia sonchifolia on serum aspartate
aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phos-
phatase (ALP) in control and experimental animals.
Groups ASTd ALTd ALPd
Normal control 125.59  0.24a 81.71  0.36a 158.62  0.26a
Azaserine control 256.38  0.34b 134.67  0.34b 278.58  0.31b
Azaserine þ plant
extract (250 mg/kg)
143.39  0.28c 96.45  0.31c 178.47  0.41c
Plant extract alone
(250 mg/kg)
125.43  0.38a 81.86  0.16a 158.54  0.46a
Values are expressed as mean  standard deviation for six animals.
Units: ALP ¼ mmoles of phenol liberated, ALT, AST ¼ mmoles of pyruvate
liberated/L.
a Groups I and IV sharing common superscript “a” do not differ significantly
at p < 0.05 (Duncan Multiple Range Test).
b,c Groups II and III with the superscripts “b” and “c”, respectively, differ
significantly at p < 0.05 (Duncan Multiple Range Test).
d Values not sharing common superscript letters differ significantly at
p < 0.05 (Duncan Multiple Range Test).compared to control group animals. Administration of the n-
hexane extract of E. sonchifolia significantly (p < 0.05)
reduced the LPO reaction in Group III animals and signifi-
cantly enhanced the enzymatic and non-enzymatic antioxi-
dants (Tables 3 and 4). There was no significant change
between the control Group I and the n-hexane extract of E.
sonchifolia alone treated Group IV animals.3.3. Effects of the n-hexane extract of E. sonchifolia in
the pancreas of control and pancreatic cancer induced
experimental animalsThe induction of pancreatic dysplasia by azaserine (Group II)
caused a significant (p < 0.05) decrease in pancreatic antioxi-
dant levels like SOD, CAT, GPx, GST, GSH, and vitamin C
compared to control Group I animals. Administration of the n-
hexane extract ofE. sonchifolia (Group III) showed a significant
(p < 0.05) increase in the pancreatic enzymatic antioxidants
SOD, CAT, GPx, GST, and non-enzymatic antioxidants GSH
and vitamin C (Tables 5 and 6). However, there was no signifi-
cant change between the control Group I and the n-hexane
extract of E. sonchifolia alone treated Group IVanimals.3.4. Histopathological studiesHistopathological examination of the pancreatic section of
rats treated with azaserine (Group II) showed atypical acini in
increased numbers (2e5 per acini). These acini revealed
enlargement of cells, nuclear enlargement with nuclear pleo-
morphism, and hyperchromasia. Moderate to severe dysplasia
was found in scattered acini. Group III rats treated with the n-
hexane extract of E. sonchifolia showed a lower number of
atypical acini. Groups I and IV showed normal pancreatic
acinar cells (Fig. 1).
Histopathological examination of the liver section of the
rats treated with azaserine (Group II) showed pleomorphic
hepatocytes having larger nuclei. The cells were arranged in a
trabecular pattern in some places. Stroma showed extensive
Table 3
Effects of the n-hexane extract of Emilia sonchifolia on the activities of enzymatic antioxidants in liver of control and experimental animals.
Particulars LPO SOD CAT GPx GST
Normal control 1.31  0.05a 8.84  0.06a 72.55  0.34a 7.46  0.26a 9.83  0.12a
Azaserine control 4.16  0.26b 3.27  0.11b 34.53  0.46b 2.45  0.26b 3.76  0.21b
Azaserine þ plant extract (250 mg/kg) 1.75  0.23c 7.61  0.32c 69.21  0.23c 6.42  0.30c 8.21  0.05c
Plant extract alone (250 mg/kg) 1.30  0.10a 8.92  0.03a 72.74  0.32a 7.41  0.27a 9.81  0.25a
Values are expressed as mean  SD for six animals.
CAT ¼ catalase; GPx ¼ glutathione peroxidase; GST ¼ glutathione-S-transferase; LPO ¼ lipid peroxidation; SOD ¼ superoxide dismutase.
Units: CAT ¼ mmol of H2O2 consumed/minute/mg protein; GPx ¼ mmol of glutathione oxidized/minute/mg protein; GST ¼ mmole of glutathione utilized/minute/
mg protein; LPO ¼ nmoles/mg protein; SOD ¼ inhibition of 50% nitrite formation/minute/mg protein.
a Groups I and IV sharing common superscript “a” do not differ significantly at p < 0.05 (Duncan Multiple Range Test).
b,c Groups II and III with the superscripts “b” and “c”, respectively, differ significantly at p < 0.05 (Duncan Multiple Range Test).
71D. Sophia et al. / Journal of Acute Medicine 4 (2014) 68e74areas of necrosis. Sinusoidal spaces were congested and cen-
tral veins dilated. Group III rats treated with the n-hexane
extract of E. sonchifolia showed normal triads and a central
venous system. Hepatocytes appeared normal. Sinusoidal
spaces also appeared normal. A few foci of necrosis were seen
in the parenchyma. Groups I and IV showed normal liver
sections (Fig. 2).
4. Discussion
The major finding of the present study was the demon-
stration for the first time that the n-hexane extract of E. son-
chifolia significantly reduced the extent of pancreatic
dysplasia induced by azaserine. Azaserine is a carcinogen in
rats and causes major abnormalities of growth and differenti-
ation of the exocrine pancreas, including adenocarcinoma in
some rats.4 In the present study, induction of pancreatic cancer
by azaserine caused exocrine pancreatic damage and hepatic
lesions.
The liver and pancreas are intimately associated with the
proper functioning of the digestive tract. The liver plays an
important role in the modulation of the process of carcino-
genesis, as it is the primary site for the biotransformation of
xenobiotics including carcinogens, as well as anticancer
drugs.19 Furthermore, a statistically significant appearance ofTable 4
Effects of the n-hexane extract of Emilia sonchifolia on the activities of non-
enzymatic antioxidants in liver of control and experimental animals.
Particulars Glutathione (GSH)d Vitamin Cd
Normal control 48.41  0.19a 1.56  0.03a
Azaserine control 21.52  0.31b 0.72  0.02b
Azaserine þ plant extract
(250 mg/kg)
39.48  0.40c 1.38  0.007c
Plant extract alone
(250 mg/kg)
48.57  0.43a 1.58  0.02a
Values are expressed as mean  SD for six animals.
Units: GSH, vitamin C ¼ mg/mg protein.
a Groups I and IV sharing common superscript “a” do not differ significantly
at p < 0.05 (Duncan Multiple Range Test).
b,c Groups II and III with the superscripts “b” and “c”, respectively, differ
significantly at p < 0.05 (Duncan Multiple Range Test).
d Values not sharing common superscript letters differ significantly at
p < 0.05 (Duncan Multiple Range Test).pancreatic and liver damage was observed in pancreatic cancer
patients. The pancreas produces amylase and lipase in large
quantities and secretes them into the small intestine. Diseases
of the pancreas most commonly cause elevated amylase and
lipase. The increase of serum amylase and lipase were found
in pancreas abnormalities.20 An increase in serum pancreatic
enzymes may also be directly associated with hepatic damage
and a reduced clearance of pancreatic enzymes by the liver
reticuloendothelial system, as postulated for advanced liver
diseases. Liver damage is also suspected to play a role in
inducing pancreatic hyperenzymemia. It is thought that
circulating pancreatic enzymes are removed by the reticulo-
endothelial system in the body, and the liver is suspected to be
a major organ for amylase removal.21 Administration of the n-
hexane extract of E. sonchifolia significantly reduced the ac-
tivity of liver and pancreatic enzymes in azaserine-induced
rats.
A marked elevation in the levels of serum AST, ALT, and
ALP, which is indicative of hepatocellular damage, was
found in Group II rats. This elevation could potentially be
attributed to the release of these enzymes from the cytoplasm
into the blood circulation after rupture of the plasma mem-
brane and cellular damage of the liver.22 The increase in ALT
and AST activity suggests a hepatic origin. They are liber-
ated only when hepatocytes are destroyed, thus reflecting
more serious hepatic disease. By contrast, the highest con-
centration of ALP is found in the intestine, liver, spleen,
bone, and kidney. Thus, the significant levels of AST, ALT,
and ALP levels confirmed the liver injury. Impaired hepa-
tocytes were thought to be the main reason for the increased
ALT, AST, and ALP activity.23
ROS and other free radicals may contribute to cancer
initiation through oxidative damage and nitration of DNA,
thus inducing mutations.2 In areas with tissue damage, in-
flammatory responses could send survival and proliferative
signals to cells repopulating the damaged area, leading to the
promotion of the growth of healthy tissues, as well as tu-
mors.24 There are data suggesting that the acinar cell damage
is followed within minutes by the production of ROS. The
primary free radical production may exacerbate the cell
damage, causing lesions of cell membranes and cytoskeleton,
impairing functions of intracellular proteins, damaging DNA,
evoking LPO, and decreasing the level of antioxidants.25
Table 5
Effects of the n-hexane extract of Emilia sonchifolia on the activities of enzymatic antioxidants in pancreas of control and experimental animals.
Particulars LPO SOD CAT GPx GST
Normal control 1.35  0.02a 6.47  0.28a 15.57  0.36a 7.59  0.37a 6.44  0.34a
Azaserine control 4.18  0.07b 2.51  0.26b 6.37  0.34b 3.46  0.32b 3.91  0.06b
Azaserine þ plant extract (250 mg/kg) 1.81  0.07c 5.91  0.05c 13.68  0.27c 6.61  0.33c 5.92  0.10c
Plant extract alone (250 mg/kg) 1.34  0.02a 6.63  0.31a 15.59  0.25a 7.62  0.33a 6.53  0.40a
Values are expressed as mean  SD for six animals.
CAT ¼ catalase; GPx ¼ glutathione peroxidase; GST ¼ glutathione-S-transferase; LPO ¼ lipid peroxidation; SOD ¼ superoxide dismutase.
Units: CAT ¼ mmol of H2O2 consumed/minute/mg protein; GPx ¼ mmol of glutathione oxidized/minute/mg protein; GST ¼ mmole of glutathione utilized/minute/
mg protein; LPO ¼ nmoles/mg protein; SOD ¼ inhibition of 50% nitrite formation/minute/mg protein.
a Groups I and IV sharing common superscript “a” do not differ significantly at p < 0.05 (Duncan Multiple Range Test).
b,c Groups II and III with the superscripts “b” and “c”, respectively, differ significantly at p < 0.05 (Duncan Multiple Range Test).
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such as 4-hydroxynoneal and MDA, which can attack cellular
targets including DNA, inducing mutagenicity and carcino-
genicity.26 Thus, enhanced LPO and failure of antioxidant
defense mechanisms lead to tissue damage. The increased
levels of LPO in the pancreas and liver of Group II cancer-
bearing animals may be due to the formation of free radicals
generated by azaserine. The observed significant reduction in
LPO in the n-hexane extract of E. sonchifolia was presumably
due to its antioxidant capacity, which has the ability to scav-
enge the free radicals.
SOD plays an important role in protecting the cells from
oxidative damage, by converting superoxide radicals into
hydrogen peroxide, which is further metabolized by CAT to
molecular oxygen and water. The increased superoxide radical
levels in tumor cells, as compared with normal cells, may
explain the decrease of the enzyme activity in malignant tis-
sues compared to normal tissues.27 Meanwhile, superoxide
radicals can increase LPO, thus increasing the generation of
reactive oxygen intermediates and MDA.28 The superoxide
radical has been shown to directly inhibit the activity of CAT.
Likewise, singlet oxygen and peroxyl radicals have been
shown to inhibit CAT activity.29 In the present study, decreased
activity of SOD and CAT was observed in the pancreas and
liver of cancer-bearing animals, and this decrease wasTable 6
Effects of the n-hexane extract of Emilia sonchifolia on the activities of non-
enzymatic antioxidants in pancreas of control and experimental animals.
Particulars Glutathione (GSH)d Vitamin Cd
Normal control 12.58  0.22a 1.44  0.02a
Azaserine control 7.47  0.37b 0.65  0.15b
Azaserine þ plant extract
(250 mg/kg)
11.55  0.24c 1.23  0.02c
Plant extract alone
(250 mg/kg)
12.70  0.11a 1.45  0.03a
Values are expressed as mean  SD for six animals.
Units: GSH, vitamin C ¼ mg/mg protein.
a Groups I and IV sharing common superscript “a” do not differ significantly
at p < 0.05 (Duncan Multiple Range Test).
b,c Groups II and III with the superscripts “b” and “c”, respectively, differ
significantly at p < 0.05 (Duncan Multiple Range Test).
d Values not sharing common superscript letters differ significantly at
p < 0.05 (Duncan Multiple Range Test).antagonized when the n-hexane extract of E. sonchifolia was
administered.
In the tissues, GPx is a major enzymatic component for the
disposal of peroxides, and a prolonged depression in the activity
of this enzyme may lead to intracellular peroxide accumulation.
GST maximizes the conjugation of free radicals and various
lipid hydroperoxides to GSH to form water-soluble products
that can be easily excreted out. Depletion in GSH levels to the
extent observed in this study could further lead to a drastic
decrease in the total antioxidant status of the body of the ani-
mals. This is because GSH helps to recycle vitamins C and E
(cellular antioxidants), blocks free radical damage, enhances the
antioxidant activity of vitamin C, and plays a critical role in the
detoxification of harmful compounds.30 Vitamin C is water-
soluble and also has an additional role in protecting or regen-
erating oxidized carotenoids or tocopherols.31 The decreased
activity of GPx, GST, GSH, and vitamin C in the pancreas and
liver of cancer-bearing animals may be due to excessive
oxidative damage. Oxidative stress-induced tissue damage can
be prevented or ameliorated by favoring the balance towards a
lower oxidative stress status. These alterations were signifi-
cantly reversed towards normal levels in the animals treatedwith
the n-hexane extract ofE. sonchifolia. The biochemical findings
were also supported by histopathological studies, which showed
the pancreatic and hepatic damage. Treatmentwith the n-hexane
extract of E. sonchifolia restored the damaged tissue to its
normalcy.
Antioxidants are potent scavengers of free radicals and
serve as inhibitors of neoplastic processes.32 Cancer chemo-
prevention using antioxidant approaches has been suggested to
offer a good potential in providing important fundamental
benefits to public health, and is now considered by many
clinicians and researchers as a key strategy for inhibiting,
delaying, or even reversal of the process of carcinogenesis.33
Therefore, the anticancer activity of the n-hexane extract of
E. sonchifolia might be due to its active components present in
it which can enhance the antioxidant activity of E. sonchifolia.
In conclusion, from these observations, it was suggested
that suppression of azaserine-induced pancreatic dysplasia and
liver damage in rats may be due to the antioxidant activity of
E. sonchifolia. Further, the potential ability of the active
constituents of E. sonchifolia against pancreatic dysplasia is
under progress in our laboratory.
Fig. 1. Histopathology of the pancreas. (A) Control rats (Group I) shows selection of normal pancreas acini. (B) Azaserine-injected rats (Group II) shows atypical
acini in increased numbers. The acini reveal enlargement of cells, nuclear enlargement with nuclear pleomorphism and hyperchromasia. Moderate to severe
dysplasia is seen. (C) Azaserine-injected rats treated with n-hexane extract of Emilia sonchifolia (Group III) show atypical acini in increased numbers. (D) n-
hexane extract of Emilia sonchifolia-only-treated rats (Group IV) shows a section of normal pancreas.
Fig. 2. Histopathology of the liver. Control rats (Group I) shows normal liver sections. (B) Azaserine-injected rats (Group II) shows pleomorphic hepatocytes
having larger nuclei. The cells are arranged in a trabecular pattern in some places. Stroma show extensive areas of necrosis. Sinusoidal spaces are congested and
central veins are dilated. (C) Azaserine-injected rats treated with n-hexane extract of Emilia sonchifolia (Group III) show normal triads and central venous system.
Hepatocytes and sinusoidal spaces appear normal. Only a few foci of necrosis are seen in the parenchyma. (D) n-hexane extract of Emilia sonchifolia-only-treated
rats (Group IV) shows a normal liver section.
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